Next Article in Journal
The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes
Previous Article in Journal
Probiotics Upregulate Trefoil Factors and Downregulate Pepsinogen in the Mouse Stomach
Open AccessArticle

The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations

1
Department of Veterinary Sciences, Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5000 Vila Real, Portugal
2
CQVR, Chemistry Department, University of Trás-os-Montes and Alto Douro (UTAD), 5000 Vila Real, Portugal
3
Laboratory for Process Engineering, Environment, Biotechnology and Energy, (LEPABE) Chemical Engineering Department, Faculty of Engineering, University of Porto (FEUP), 4000 Porto, Portugal
4
Molecular Oncology and Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Institute of Oncology of Porto (IPO-Porto), 4000 Porto, Portugal
5
School of Health Dr. Lopes Dias, IPC, 6000 Castelo Branco, Portugal
6
Mountain Research Centre (CIMO), IPB, 5300 Bragança, Portugal
7
Advanced Polytechnic and University Cooperative (CESPU), Institute of Research and Advanced Training in Health Sciences and Technologies (IINFACTS), 4585 Gandra, Portugal
8
Research Center in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto, 4000 Porto, Portugal
9
Faculty of Medicine, University of Porto (FMUP), 4000 Porto, Portugal
10
CEBIMED, Faculty of Health Sciences, Fernando Pessoa University, 4000 Porto, Portugal
11
LPCC Research Department, Portuguese League against Cancer (NRNorte), 4000 Porto, Portugal
12
Department of Genetics and Biotechnology and Animal and Veterinary Research Centre (CECAV), University of Trás-os-Montes and Alto Douro (UTAD), 5000 Vila Real, Portugal
13
CQVR, Biology and Environment Department, University of Trás-os-Montes and Alto Douro (UTAD), 5000 Vila Real, Portugal
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(16), 3902; https://doi.org/10.3390/ijms20163902
Received: 28 June 2019 / Revised: 8 August 2019 / Accepted: 9 August 2019 / Published: 10 August 2019
(This article belongs to the Section Molecular Toxicology)
Carcinogenesis induced by high-risk human papillomavirus (HPV) involves inflammatory phenomena, partially mediated by cyclooxigenase-2. In pre-clinical models of HPV-induced cancer, cyclooxygenase-2 inhibitors have shown significant efficacy, but also considerable toxicity. This study addresses the chemopreventive effect and hepatic toxicity of a specific cyclooxigensase-2 inhibitor, parecoxib, in HPV16-transgenic mice. Forty-three 20 weeks-old female mice were divided into four groups: I (HPV16−/−, n = 10, parecoxib-treated); II (HPV16−/− n = 11, untreated); III (HPV16+/−, n = 11, parecoxib-treated) and IV (HPV16+/−, n = 11, untreated). Parecoxib (5.0 mg/kg once daily) or vehicle was administered intraperitoneally for 22 consecutive days. Skin lesions were classified histologically. Toxicological endpoints included genotoxic parameters, hepatic oxidative stress, transaminases and histology. Parecoxib completely prevented the onset of epidermal dysplasia in HPV16+/− treated animals (0% versus 64% in HPV16+/− untreated, p = 0.027). Parecoxib decreases lipid peroxidation (LPO) and superoxide dismutase (SOD) activity and increases the GSH:GSSG ratio in HPV16+/− treated animals meaning that oxidative stress is lower. Parecoxib increased genotoxic stress parameters in wild-type and HPV16-transgenic mice, but didn’t modify histological or biochemical hepatic parameters. These results indicate that parecoxib has chemopreventive effects against HPV16-induced lesions while maintaining an acceptable toxicological profile in this model. View Full-Text
Keywords: COX-2; NSAID; in vivo; K14HPV16 COX-2; NSAID; in vivo; K14HPV16
Show Figures

Figure 1

MDPI and ACS Style

Ferreira, T.; Campos, S.; Silva, M.G.; Ribeiro, R.; Santos, S.; Almeida, J.; Pires, M.J.; Gil da Costa, R.M.; Córdova, C.; Nogueira, A.; Neuparth, M.J.; Medeiros, R.; Monteiro Bastos, M.M.S.; Gaivão, I.; Peixoto, F.; Oliveira, M.M.; Oliveira, P.A. The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations. Int. J. Mol. Sci. 2019, 20, 3902.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop